Competitive Advantages // Chi-Med
AIM: £45.45 (-0.15) | Nasdaq: $29.36 (-0.31)
Competitive Advantages

Household Brands

ShangYaoPai_clean
BaiYunShan
Shang Yao
Baiyunshan
Rx brand
(“Shanghai Medicine”)
OTC brand
(a famous scenic
area in Guangzhou)

Focus on the largest disease categories

Most common diseases diagnosed/treated in rural hospitals:[1]

Cold/flu 86%
Cardiovascular diseases 78%
Diabetes 46%
Gastrointestinal diseases 45%

Major commercial & production scale

~4.6 billion doses of medicine sold in 2017

~2,400 Prescription & ~1,000 OTC sales people

About 300 cities & towns[2] in China

~22,900 hospitals

~106,000 doctors detailed

Leadership market shares

Market leader in the sub-categories in which we compete:[3]

She Xiang Bao Xin Pill:[4]
Rx Cardiovascular TCM		 ~15%
Banlangen Granules:
OTC Anti-viral TCM		 ~53%
Fu Fang Dan Shen tablets:
OTC Angina TCM		 ~38%

JVs with 3 leading China pharma companies

 
     
Shanghai Pharmaceuticals
Sinopharm
Guangzhou Pharmaceuticals

Extensive domestic coverage

 

Our products have extensive representation:

  • Medicines Catalogue for the National Basic Medical Insurance
  • Labour Injury Insurance and Childbirth Insurance Systems
  • National Essential Medicines List, which mandates distribution of drugs in China

[1] Frost & Sullivan; [2] 300 cities & towns covered by Prescription Drug Business and 600 cities & towns including OTC business; [3] Frost & Sullivan 2017 market share data; [4] China coronary heart disease oral Chinese patented drugs market share.